The Natural History of Hypertension with Moderate Impairment of Renal Function

1973 ◽  
Vol 45 (s1) ◽  
pp. 191s-193s
Author(s):  
G. E. Bauer ◽  
T. J. Humphery

1. A continuing prospective study of patients with severe hypertension is now in its eighteenth year. 2. Patients with impaired renal function survive longer with present-day management if control of pressure is good and if renal structural abnormalities are not gross. 3. Since 1960 myocardial infarction, rather than cerebrovascular accident, has been the commonest cause of death.

2019 ◽  
Vol 33 (1) ◽  
pp. 9-35 ◽  
Author(s):  
Giuseppe Pugliese ◽  
◽  
Giuseppe Penno ◽  
Andrea Natali ◽  
Federica Barutta ◽  
...  

Abstract Aims This joint document of the Italian Diabetes Society and the Italian Society of Nephrology reviews the natural history of diabetic kidney disease (DKD) in the light of the recent epidemiological literature and provides updated recommendations on anti-hyperglycemic treatment with non-insulin agents. Data Synthesis Recent epidemiological studies have disclosed a wide heterogeneity of DKD. In addition to the classical albuminuric phenotype, two new albuminuria-independent phenotypes have emerged, i.e., “nonalbuminuric renal impairment” and “progressive renal decline”, suggesting that DKD progression toward end-stage kidney disease (ESKD) may occur through two distinct pathways, albuminuric and nonalbuminuric. Several biomarkers have been associated with decline of estimated glomerular filtration rate (eGFR) independent of albuminuria and other clinical variables, thus possibly improving ESKD prediction. However, the pathogenesis and anatomical correlates of these phenotypes are still unclear. Also the management of hyperglycemia in patients with type 2 diabetes and impaired renal function has profoundly changed during the last two decades. New anti-hyperglycemic drugs, which do not cause hypoglycemia and weight gain and, in some cases, seem to provide cardiorenal protection, have become available for treatment of these individuals. In addition, the lowest eGFR safety thresholds for some of the old agents, particularly metformin and insulin secretagogues, have been reconsidered. Conclusions The heterogeneity in the clinical presentation and course of DKD has important implications for the diagnosis, prognosis, and possibly treatment of this complication. The therapeutic options for patients with type 2 diabetes and impaired renal function have substantially increased, thus allowing a better management of these individuals.


1987 ◽  
Vol 60 (4) ◽  
pp. 219-224 ◽  
Author(s):  
Thomas H. Lee ◽  
Gregory W. Rouan ◽  
Monica C. Weisberg ◽  
Donald A. Brand ◽  
Denise Acampora ◽  
...  

2021 ◽  
Vol 10 (23) ◽  
pp. 5677
Author(s):  
Mohammad A. Almesned ◽  
Femke M. Prins ◽  
Erik Lipšic ◽  
Margery A. Connelly ◽  
Erwin Garcia ◽  
...  

The gut metabolite trimethylamine N-oxide (TMAO) at admission has a prognostic value in ST-elevation myocardial infarction (STEMI) patients. However, its sequential changes and relationship with long-term infarct-related outcomes after primary percutaneous coronary intervention (PCI) remain elusive. We delineated the temporal course of TMAO and its relationship with infarct size and left ventricular ejection fraction (LVEF) post-PCI, adjusting for the estimated glomerular filtration rate (eGFR). We measured TMAO levels at admission, 24 h and 4 months post-PCI in 379 STEMI patients. Infarct size and LVEF were determined by cardiac magnetic resonance 4 months after PCI. TMAO levels decreased from admission (4.13 ± 4.37 μM) to 24 h (3.41 ± 5.84 μM, p = 0.001) and increased from 24 h to 4 months (3.70 ± 3.86 μM, p = 0.026). Higher TMAO values at 24 h were correlated to smaller infarct sizes (rho = −0.16, p = 0.024). Larger declines between admission and 4 months suggestively correlated with smaller infarct size, and larger TMAO increases between 24 h and 4 months were associated with larger infarct size (rho = −0.19, p = 0.008 and rho = −0.18, p = 0.019, respectively). Upon eGFR stratification using 90 mL/min/1.73 m2 as a cut-off, significant associations between TMAO and infarct size were only noted in subjects with impaired renal function. In conclusion, TMAO levels in post-PCI STEMI patients are prone to fluctuations, and these fluctuations could be prognostic for infarct size, particularly in patients with impaired renal function.


CHEST Journal ◽  
1993 ◽  
Vol 103 (5) ◽  
pp. 1320-1324 ◽  
Author(s):  
Seishi Nakamura ◽  
Toshiji Iwasaka ◽  
Tetsuro Sugiura ◽  
Naohiko Ohkubo ◽  
Hisako Tsuji ◽  
...  

2013 ◽  
Vol 20 (5) ◽  
pp. 526-532 ◽  
Author(s):  
Joon Seok Choi ◽  
Min Jee Kim ◽  
Yong Un Kang ◽  
Chang Seong Kim ◽  
Eun Hui Bae ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document